A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine if the advised dose of ramucirumab is safe to
be taken with chemotherapy treatment in participants with advanced liver tumors.